Zhejiang Jolly Pharmaceutical Co.,LTD

Shenzhen Stock Exchange 300181.SZ

Zhejiang Jolly Pharmaceutical Co.,LTD Share Price on January 27, 2025: USD 2.03

Zhejiang Jolly Pharmaceutical Co.,LTD Share Price is USD 2.03 on January 27, 2025, a 44.58% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.
  • Zhejiang Jolly Pharmaceutical Co.,LTD 52-week high Share Price is USD 2.47 on November 11, 2024, which is 21.55% above the current Share Price.
  • Zhejiang Jolly Pharmaceutical Co.,LTD 52-week low Share Price is USD 1.22 on February 02, 2024, which is -39.91% below the current Share Price.
  • Zhejiang Jolly Pharmaceutical Co.,LTD average Share Price for the last 52 weeks is USD 2.00.
Key data
Date Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B)
Market news
Loading...
SV Wall Street
Shenzhen Stock Exchange: 300181.SZ

Zhejiang Jolly Pharmaceutical Co.,LTD

CEO Mr. Tao Wang
IPO Date Feb. 22, 2011
Location China
Headquarters No. 388, Zhiyuan North Road
Employees 2,687
Sector Healthcare
Industries
Description

Zhejiang Jolly Pharmaceutical Co., Ltd. engages in the research, production, and marketing of Chinese medicinal products in China and internationally. The company offers Wuling capsule that is used to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kidney, or neurasthenia. It also provides Lingze tablet, which is used to treat frequent urination, dysuria, weak steam of urine, endless urine, and soreness and weakness of waist and knees caused by benign prostatic hyperplasia, kidney deficiency, and blood stasis; and Bailing tablet that is used as the adjuvant therapy to treat cough, asthma, back pain, and chronic bronchitis, which are caused by the deficiency of lungs and kidney. In addition, the company offers Linglianhua particles for the treatment of symptoms, including sweating, insomnia, dysphoria, heart palpitations, dreaminess, giddy tinnitus, lassitude in loin and legs, dry stool, and abnormal furred tongue, as well as weak pulse caused by perimenopausal syndrome, or disharmony of heart and kidney. Further, it provides azithromycin, clindamycin phosphate, doxapram, pefloxacin mesylate, adenosine cyclophosphate, and sodium nitroprusside injections. Additionally, the company offers materials, such as cordyceps cephalosporium, fermented cordyceps, and Wuling powders. It also invests and participates in the medical services of Deqing No.3 People's Hospital. The company was formerly known as Zhejiang Jolly Pharmaceutical Health Products Co., LTD. and changed its name to Zhejiang Jolly Pharmaceutical Co., Ltd. in 1998. Zhejiang Jolly Pharmaceutical Co., Ltd. was founded in 2000 and is based in Huzhou, China.

StockViz Staff

February 2, 2025

Any question? Send us an email